Clinical trial
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
NCT00115778 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00115778 |
|---|---|
| Title | Intravenous Immunoglobulin (IVIG) in Lung Transplantation |
| Official title | IVIG for Acquired Immunodeficiency in Lung Transplant Patients |
| Lead sponsor | Columbia University, Other |
| Collaborators | Grifols Therapeutics LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypogammaglobulinemia, Lung Transplantation |
| Intervention type | Drug, Other |
| Interventions | IVIG, Placebo |
| Enrollment | 11 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Jun 27, 2005 |
| Last update posted | Mar 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: